Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming

Being able to "age" up to 80-100 years is a triumphant hallmark of human evolution. Unfortunately, human aging in the modern era has become synonymous with poor health. Thus, strategies to promote healthy aging are urgently needed to ensure a sustainable future for humanity. Modern-day evidence clearly shows that the immune system is one of the key mechanisms that govern aging. Unfortunately, immunological competence becomes senescent with age. This age-associated immune senescence represents a major therapeutic target to address age-related health issues. Recent advances in the field of "immunometabolomics" reveal that metabolic pathways play a central role in age-associated immune senescence. Thus, metabolism reprogramming innovations targeting immune senescence are key to reinstating desired immune competence in aged hosts. The rapid expansion of nanoparticle science promises to accelerate therapeutic metabolic reprogramming strategies and represents a new frontier for targeting immune senescence. In this perspective, we discuss opportunities for nanoparticle-based systems designed to rejuvenate immunity and promote healthy aging.

Authors

Institutions

Publication Details

Journal
ACS Nano
Published
2026-05-08
DOI
https://doi.org/10.1021/acsnano.5c18638
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming

Susan E. Howlett, Preethi Gopalakrishnan Nair, Vishnu Vijay Vijayan, Unnikrishnan Babukuttan Sheela et al.
ACS Nano
Telomeres, Telomerase, and Senescence
article

Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming

Susan E. Howlett, Preethi Gopalakrishnan Nair, Vishnu Vijay Vijayan, Unnikrishnan Babukuttan Sheela, Shashi Gujar, Pieter Cullis
article en

Abstract

Being able to "age" up to 80-100 years is a triumphant hallmark of human evolution. Unfortunately, human aging in the modern era has become synonymous with poor health. Thus, strategies to promote healthy aging are urgently needed to ensure a sustainable future for humanity. Modern-day evidence clearly shows that the immune system is one of the key mechanisms that govern aging. Unfortunately, immunological competence becomes senescent with age. This age-associated immune senescence represents a major therapeutic target to address age-related health issues. Recent advances in the field of "immunometabolomics" reveal that metabolic pathways play a central role in age-associated immune senescence. Thus, metabolism reprogramming innovations targeting immune senescence are key to reinstating desired immune competence in aged hosts. The rapid expansion of nanoparticle science promises to accelerate therapeutic metabolic reprogramming strategies and represents a new frontier for targeting immune senescence. In this perspective, we discuss opportunities for nanoparticle-based systems designed to rejuvenate immunity and promote healthy aging.

ACS Nano
Dalhousie University (CA), University of British Columbia (CA), Kyoto University (JP), Beatrice Hunter Cancer Research Institute (CA), Immunité et Cancer (FR)
Heart and Stroke Foundation of Canada, Government of Canada, Canadian Cancer Society, Canada Foundation for Innovation, Research Nova Scotia, Institute of Cancer Research
Zero hunger
Openalex Percentile: Top 7%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.